{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-033738","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2026-08-19T20:04:17+00:00","discovered_at":"2026-08-19T20:05:09.318184+00:00","generated_at":"2026-08-19T20:05:18.767495+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Crinetics supplements proxy disclosures amid shareholder lawsuits over Vertex merger","bullets":["Three shareholder lawsuits filed Aug 6 & 17, 2026 in NY and CA allege misleading proxy disclosures; seek to block merger.","Board unanimously reaffirms 'FOR' recommendation on merger and related proposals; special shareholder meeting set for Aug 28, 2026.","Supplemental disclosures add J.P. Morgan and Leerink valuation analyses; updated projections show revenue rising to $1,057M by 2030E and $4,583M by 2035E.","Advisor fees disclosed: J.P. Morgan ~$69.4M and Leerink ~$60.8M, largely contingent on $85.00/share deal closing.","Company denies allegations, says proxy complies with law; voluntary supplements made to avoid nuisance and potential delays."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-033738","json":"https://secwatch.observer/filing/0001140361-26-033738.json","markdown":"https://secwatch.observer/filing/0001140361-26-033738.md","text":"https://secwatch.observer/filing/0001140361-26-033738.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126033738/0001140361-26-033738-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126033738/ef20080494_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-19T20:05:18.767495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}